CHILI 5.0

Conference on Hybrid Imaging Live

  • 16 Lectures
  • 510 Minutes
  • 17 Speakers

Lectures

1
1 - INNOVATION FOR HYBRID IMAGING

1 - INNOVATION FOR HYBRID IMAGING

135:19CHILI 5.0

ImmunoPET in clinical decision guidance of immunotherapy
Maria Jose Garcia Velloso, Pamplona /ESP

Total body PET/CT – the game changer?
Axel Rominger, Bern /CH

How to set up a therapnostic center
Mike Sathekge, Pretoria /ZAF

AI in multimodality hybrid imaging
Irene Buvat, Orsay /FR

Discussion and Q&A with the experts
Moderation: Clemens Cyran & Thomas Beyer

2
2 - ONCOLOGY - GUIDELINES AND STANDARD OF CLINICAL CARE

2 - ONCOLOGY - GUIDELINES AND STANDARD OF CLINICAL CARE

108:23CHILI 5.0

PET/CT for Radiation Therapy Planning
Danijela Dejanovic, Copenhagen /DK

FDG PET/CT for monitoring immunotherapy
Egesta Lopci, Rozzano /IT

Therapeutic management of lymphoma including with PET/CT (incl. CAR-T)
Marcus Unterrainer, Munich /DE

Breast Cancer therapy guidance with FDG PET/CT
Katja Pinker-Domenig, New York /US

Discussion and Q&A with the experts
Moderation: Clemens Cyran & Thomas Beyer

3
3 - INFECTION AND INFLAMMATION

3 - INFECTION AND INFLAMMATION

106:14CHILI 5.0

An update on novel developments in hybrid imaging of infection and inflammation
Ora Israel, Haifa /ISR

Hybrid imaging in inflammatory diseases
Jose Vercher Conejero, Barcelona /ESP

Bone SPECT/CT in orthopedics
Klaus Strobel, Lucerne /CH

TAU PET/MR in dementia
Alexander Hammers, United Kingdom

Discussion and Q&A with the experts
Moderation: Clemens Cyran & Thomas Beyer

4
SPONSORED SYMPOSIUM & DISCUSSION - BAYER

SPONSORED SYMPOSIUM & DISCUSSION - BAYER

31:20CHILI 5.0

Radiation Dose Reduction and Dose Optimisation in PET Imaging
Ana Matos, United Kingdom

Discussion and Q&A

5
4 - THERANOSTICS

4 - THERANOSTICS

109:31CHILI 5.0

Theranostics in NET – State of the art and future perspectives
Harun Ilhan, Munich /DE

FAPI in oncologic imaging – the next FDG?
Frederik Giesel, Heidelberg /DE

Hybrid imaging and theranostics in meningeoma
Betty Salgues, France

Prospective studies in prostate cancer therapy guidance by PSMA PET/CT
Jeremie Calais, Santa Monica /US

Discussion and Q&A with the experts
Moderation: Clemens Cyran & Thomas Beyer

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.

Moderators

  • Thomas Beyer

    Vienna / Austria
  • Clemens Cyran

    Munich / Germany

Speakers

  • MARIA JOSE GARCIA GARCIA VELLOSO

    Pamplona / Spain
  • Mike Sathekge

    Pretoria / South Africa
  • Axel Rominger

    Bern / Switzerland
  • Irène Buvat

    Orsay / France
  • Danijela Dejanovic

    Copenhagen / Denmark
  • Egesta Lopci

    Rozzano / Italy
  • Marcus Unterrainer

    Munich / Germany
  • Katja Pinker-Domenig

    New York / United States
  • Ora Israel

    Haifa / Israel
  • Jose Luis Vercher Conejero

    Barcelona / Spain